Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2 USD | +3.63% | +18.34% | +41.84% |
Financials (USD)
Sales 2024 * | 325K | Sales 2025 * | 7.46M | Capitalization | 138M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -60M | EV / Sales 2024 * | 425 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 18.5 x |
P/E ratio 2024 * |
-2.18
x | P/E ratio 2025 * |
-2.55
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.42% |
Latest transcript on aTyr Pharma, Inc.
1 day | +3.63% | ||
1 week | +18.34% | ||
Current month | +27.39% | ||
1 month | +23.46% | ||
3 months | -0.99% | ||
6 months | +75.44% | ||
Current year | +41.84% |
Managers | Title | Age | Since |
---|---|---|---|
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 16-03-29 |
Jill Broadfoot
DFI | Director of Finance/CFO | 63 | 18-07-29 |
Lisa Carey
CTO | Chief Tech/Sci/R&D Officer | - | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Schimmel
FOU | Founder | 83 | 05-09-07 |
Tim Coughlin
CHM | Chairman | 57 | 17-04-09 |
John Clarke
BRD | Director/Board Member | 70 | 05-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 2 | +3.63% | 577,288 |
24-05-16 | 1.93 | +0.78% | 423,218 |
24-05-15 | 1.915 | +5.22% | 489,550 |
24-05-14 | 1.82 | +7.06% | 415,503 |
24-05-13 | 1.7 | +0.59% | 4,636,559 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.84% | 138M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- LIFE Stock